The visibility of cancer on earlier mammograms in a population-based screening programme

European Journal of Cancer

Volumn 35, Issue 7, 1999, Pages 1118-1122

  Saarenmaa, I ^a   Salminen, T ^b   Geiger, U ^a   Holli, K ^c   Isola, J ^d   Karkkainen A ^d   Pakkanen, J ^a   Piironen, A ^e   Salo, A ^e   Hakama, M ^b,f  

^a Cancer Society of Tampere Region   (Finland)

^b UNIVERSITY OF TAMPERE   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^e Tampere City Hospital   (Finland)

^f FINNISH CANCER REGISTRY   (Finland)

Author keywords

Finland; Mammography; Screening

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; BREAST EXAMINATION; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER SCREENING; CLINICAL FEATURE; FEMALE; FINLAND; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PRIORITY JOURNAL; RADIOLOGIST; TUMOR VOLUME;

BREAST NEOPLASMS; FEMALE; FINLAND; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES;

EID: 0033166511     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(99)00103-3     Document Type: Article

References (16)

1. Shapiro S., Venet W., Strax P., Venet L., Roeser R. Ten to fourteen-year effect of screening on breast cancer mortality. J. Natl. Cancer Inst. 69:1982;349-355.
2. Tabar L., Gad A., Holmberg L.H.et al. Reduction in mortality from breast cancer after mass screening with mammography. Lancet. i:1985;829-832.
3. de Koning H.J., Fracheboyd J., Boer R.et al. National evaluation team for breast cancer screening (NETB). Nation-wide breast cancer screening in the Netherlands. support for breast cancer mortality reduction Int. J. Cancer. 60:1995;777-780.
4. Hakama M., Pukkala E., Heikkilä M., Kallio M. Effectiveness of the public health policy for breast cancer screening in Finland. population based cohort study Br. Med. J. 314:1997;864-867.
5. Hakama M., Elovainio L., Kajantie R., Louhivuori K. Breast cancer screening as public health policy in Finland. Br. J. Cancer. 64:1991;962-964.
6. Ma L., Fishell E., Wright B., Hanna W., Allan S., Boyd N.F. Case-control study of factors associated with failure to detect breast cancer by mammography. J. Natl. Cancer Inst. 84:1992;781-785.
7. Jones R.D., Mclean L., Young J.R., Simpson W., Neilson F. Proportion of cancers detected at the first incident screen which were false negative at the prevalent screen. Breast. 5:1996;339-343.
8. Bird R.E., Wallace T.W., Yankaskas B.C. Analyses of cancers missed at screening mammography. Radiology. 184:1992;613-617.
9. Harvey J.A., Fajardo L.L., Innis C.A. Previous mammograms in patients with impalpable breast carcinoma. retrospective vs blinded interpretation AJR. 161:1993;1167-1172.
10. Simpson W., Neilson F., Young J.R. the Northern Region Breast Screening Radiology Audit Group The identification of false negatives in a population of interval cancers. a method for audit of screening mammography Breast. 4:1995;183-188.
11. van Dijck J.A.A.M., Verbeek A.L.M., Hendriks J.H.C.L., Holland R. The current detectability of breast cancer in a mammographic screening program. A review of the previous mammograms of interval and screen-detected cancers. Cancer. 72:1993;1932-1938.
12. Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research. Cancer Statistics of the National Research and Development Centre for Welfare and Health. Cancer incidence in Finland 1992, Cancer Society of Finland; Publication No. 54, Helsinki, 1994.
13. Maes R.M., Dronkers D.J., Hendrics J.H.C.L., Thijssen M.A.O., Nab H.W. Do non-specific minimal signs in biennal mammographic breast cancer screening programme need further diagnostic assessment? Br. J. Radiol. 70:1997;34-38.
14. Burrell H.C., Sibbering D.M., Wilson A.R.M.et al. Screening interval breast cancers. mammographic features and prognostic factors Radiology. 199:1996;811-817.
15. Ikeda D.M., Andersson I., Wattsgård C.et al. Interval carcinomas in the Malmö Mammographic Screening Trial. radiographic appearance and prognostic considerations AJR. 159:1992;287-294.
16. Peeters P.H.M., Verbeek A.L.M., Hendriks J.H.C.L., Holland R., Mravunac M. The occurrence of interval cancers in the Nijmegen screening programme. Br. J. Cancer. 59:1989;929-932.